SkyAI, Inc.(SKYA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,609 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
SKYA Stock Analysis & AI Quality Score
AI stock analysis and institutional research for SkyAI, Inc. (SKYA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SKYA at 23.5/100 on a 32-signal composite quality model, placing it at rank #2,609 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (1.8) and institutional flow (12.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 1.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), SkyAI, Inc. reports quarterly revenue of $192.8K, net income of $-86.2M, free cash flow of $-2.7M. SKYA trades on the Nasdaq exchange and files with the SEC under CIK 1737995. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SKYA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SkyAI, Inc. directly from SEC EDGAR. SkyAI, Inc.'s 13F Pro composite quality score has ranged between 23 and 28 since 2026, currently 23.5 — a declining long-term trajectory across 8 quarterly and live scoring snapshots.
Revenue
Q1 2026
$192.8K
Net Income
Q1 2026
$-86.2M
Free Cash Flow
Q1 2026
$-2.7M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
Net Income
-2938.9% YoYOperating Income
-4744.7% YoYEPS (Diluted)
+99.5% YoYTotal Assets
+3579.0% YoYTotal Debt
Op. Cash Flow
-149.7% YoY| Metric | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue | $204.1K | — | — | — | — |
| Net Income | $-282.5M -2938.9% | $-9.3M -100.4% | $-4.6M +0.5% | $-4.7M | — |
| Operating Income | $-269.7M -4744.7% | $-5.6M +36.3% | $-8.7M -94.3% | $-4.5M | — |
| EPS (Diluted) | $-11.16 +99.5% | $-2219.92 -389359.6% | $-0.57 | — | — |
| Total Assets | $269.1M +3579.0% | $7.3M -38.2% | $11.8M +100.6% | $5.9M | — |
| Total Debt | $3.1M | — | — | — | — |
| Operating Cash Flow | $-11.0M -149.7% | $-4.4M +31.6% | $-6.4M -104.4% | $-3.1M | — |
AI Insight: SKYA Ratio Trends
Sharps Technology swung violently from profitability in Q2 2025 (ROE 97.9%) to severe losses in Q1 2026 (ROE −192.9%), signaling operational instability.
• ROE collapsed from +97.9% in Q2 2025 to −192.9% in Q1 2026, the worst quarter in the dataset.
• ROA swung from +83.3% in Q2 2025 to −94.9% in Q3 2025, indicating severe profitability deterioration.
• ROIC negative across all measured quarters (Q1 2025 through Q3 2025: −79.8% to −93.1%), destroying shareholder value.
• Leverage remains minimal (D/E 0.01–0.02 TTM), providing financial flexibility amid earnings distress.
⚠ Q1 2026 represents the fifth consecutive quarter of ROIC deep in negative territory — sustainability of business model is in question.
⚠ Extreme quarter-to-quarter volatility in ROE and ROA suggests underlying operational or accounting irregularities; root cause unclear from ratios alone.
Get alerted when SKYA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for SkyAI, Inc. including:
Top Institutional Holders of SKYA
SIMPLEX TRADING, LLC
$1.2K700 sh
| Fund | Value | Shares |
|---|---|---|
| SIMPLEX TRADING, LLC | $1.2K | 700 |
More Healthcare Companies
View all Healthcare →Put SKYA on your watchlist
Track score changes the day SkyAI, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SKYA a good stock to buy?
13F Pro's AI-powered analysis of SkyAI, Inc. (SKYA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SKYA are available on the SKYA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own SKYA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SKYA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of SkyAI, Inc.'s investment landscape.